H1 Hip Resurfacing Arthroplasty
NCT: NCT03326804 · ACTIVE_NOT_RECRUITING
Brief Summary
This is a prospective, non-randomized, consecutive series, multicentre, observational study to evaluate the clinical outcome of ceramic-on- ceramic hip resurfacing arthroplasty using the ceramic, non-porous, non-cemented H1 Hip Resurfacing Arthroplasty. It includes a safety study followed by an efficacy study. Patients will be followed up for 10-years postoperatively. The primary aim is to confirm the safety of the H1 hip resurfacing prosthesis by demonstrating non-inferiority of the H1 device in terms of survivorship. The secondary is to evaluate superiority of the ceramic-on-ceramic H1 hip resurfacing prosthesis compared to Metal-on-Metal (MoM) hip resurfacing in terms of absence of metal ion release.The primary end point is revision for any reason.
Frequently Asked Questions
What is H1 Hip Resurfacing Arthroplasty?
H1 Hip Resurfacing Arthroplasty is a clinical trial registered under NCT03326804. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03326804?
The current status of NCT03326804 (H1 Hip Resurfacing Arthroplasty) is: ACTIVE_NOT_RECRUITING.
When did H1 Hip Resurfacing Arthroplasty start?
H1 Hip Resurfacing Arthroplasty started on 2017-09-26.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.